ENBI.CN
Price:
$0.1
Market Cap:
$885.89K
Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.[Read more]
Industry
Biotechnology
IPO Date
2018-05-03
Stock Exchange
CNQ
Ticker
ENBI.CN
According to Entheon Biomedical Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -1.67. This represents a change of -40.17% compared to the average of -2.79 of the last 4 quarters.
The mean historical PE Ratio of Entheon Biomedical Corp. over the last ten years is -49100.76. The current -1.67 PE Ratio has changed -99.66% with respect to the historical average. Over the past ten years (40 quarters), ENBI.CN's PE Ratio was at its highest in in the June 2017 quarter at 150.98K. The PE Ratio was at its lowest in in the September 2019 quarter at -375.84.
Average
-49100.76
Median
-4.76
Minimum
-434990.57
Maximum
-0.25
Discovering the peaks and valleys of Entheon Biomedical Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.45%
Maximum Annual PE Ratio = -0.25
Minimum Annual Increase = -99.96%
Minimum Annual PE Ratio = -434990.57
Year | PE Ratio | Change |
---|---|---|
2023 | -1.97 | 681.32% |
2022 | -0.25 | -92.54% |
2021 | -3.38 | -29.02% |
2020 | -4.76 | 192.44% |
2020 | -1.63 | -98.36% |
2019 | -99.59 | -40.36% |
2018 | -166.99 | -99.96% |
2017 | -434990.57 | 6.45% |
The current PE Ratio of Entheon Biomedical Corp. (ENBI.CN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.87
5-year avg
-2.40
10-year avg
-49100.76
Entheon Biomedical Corp.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entheon Biomedical Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Entheon Biomedical Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Entheon Biomedical Corp.'s PE Ratio?
How is the PE Ratio calculated for Entheon Biomedical Corp. (ENBI.CN)?
What is the highest PE Ratio for Entheon Biomedical Corp. (ENBI.CN)?
What is the 3-year average PE Ratio for Entheon Biomedical Corp. (ENBI.CN)?
What is the 5-year average PE Ratio for Entheon Biomedical Corp. (ENBI.CN)?
How does the current PE Ratio for Entheon Biomedical Corp. (ENBI.CN) compare to its historical average?